Abrdn Life Sciences Investors Fund (HQL)
Abrdn Life Sciences Investors Fund (HQL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2007 | 09-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | 50,510 | -21,440 |
| Other Working Capital | -32,080 | 33,830 |
| Other Operating Activity | -7,800 | -72,680 |
| Operating Cash Flow | $10,630 | $-60,290 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $0 | $0 |
| Cash Flows From Financing Activities | ||
| Dividend Paid | -10,630 | -11,130 |
| Other Financing Activity | 0 | 71,400 |
| Financing Cash Flow | $-10,630 | $60,270 |
| Beginning Cash Position | 2 | 20 |
| End Cash Position | 1 | 1 |
| Net Cash Flow | $-1 | $-20 |
| Free Cash Flow | ||
| Operating Cash Flow | 10,630 | -60,290 |
| Free Cash Flow | 10,630 | -60,290 |